TAF
BITI

Tredje AP-fonden’s BIOTIE THERAPIES CORP SPONSORED ADR BITI Stock Holding History

Tredje AP-fonden’s Portfolio BITI Stock Details BITI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-66,500
Closed -$1.74M – 303
2015
Q2 		$1.74M Buy
+66,500
New +$1.39M 0.14% 180

Other funds holding BITI

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Tredje AP-fonden's BITI Position: Q3 2015 in Review

Tredje AP-fonden sold out of BIOTIE THERAPIES CORP SPONSORED ADR (BITI) in Q3 2015, closing a stake of 66,500 shares — an estimated $1.74M sold.

Tredje AP-fonden first reported a position in BITI in Q2 2015 and held it in 1 quarter. The position peaked at $1.74M in Q2 2015. 15 funds tracked by Wall St. Rank hold BITI as of Q3 2015.

  • Tredje AP-fonden reported no remaining BIOTIE THERAPIES CORP SPONSORED ADR position as of Q3 2015 after selling out during the quarter.
  • Tredje AP-fonden sold 66,500 BIOTIE THERAPIES CORP SPONSORED ADR shares in Q3 2015, an estimated $1.74M.
  • Tredje AP-fonden first reported a position in BIOTIE THERAPIES CORP SPONSORED ADR in Q2 2015 and held it in 1 quarter.
  • Tredje AP-fonden's BIOTIE THERAPIES CORP SPONSORED ADR position peaked at $1.74M in Q2 2015.
  • 15 funds tracked by Wall St. Rank held BIOTIE THERAPIES CORP SPONSORED ADR as of Q3 2015.

Based on Tredje AP-fonden's 13F filing for Q3 2015, filed 10 Nov 2015.